Pictet Asset Management (UK)’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | $540K | Sell |
22,532
-543,197
| -96% | -$13M | ﹤0.01% | 1197 |
|
2021
Q1 | $14.5M | Sell |
565,729
-280,820
| -33% | -$7.21M | 0.02% | 569 |
|
2020
Q4 | $16.1M | Sell |
846,549
-7,204
| -0.8% | -$137K | 0.02% | 515 |
|
2020
Q3 | $10.7M | Buy |
853,753
+27,878
| +3% | +$351K | 0.02% | 538 |
|
2020
Q2 | $9.99M | Buy |
825,875
+194,466
| +31% | +$2.35M | 0.02% | 527 |
|
2020
Q1 | $4.83M | Buy |
631,409
+9,039
| +1% | +$69.1K | 0.01% | 646 |
|
2019
Q4 | $11.1M | Buy |
622,370
+76,895
| +14% | +$1.37M | 0.02% | 543 |
|
2019
Q3 | $6.33M | Buy |
545,475
+90,989
| +20% | +$1.06M | 0.01% | 635 |
|
2019
Q2 | $10.1M | Buy |
+454,486
| New | +$10.1M | 0.02% | 515 |
|